|
2-(3,4-Dihydroxyphenyl)Acetic Acid
|
DB01702 |
[A deaminated metabolite of levodopa. [PubChem]] |
|
2-phospho-D-glyceric acid
|
DB01709 |
[A 2-phosphoglyceric acid in which the glyceric acid moiety has D (R) configuration.] |
|
Prasterone
|
DB01708 |
[Prasterone, also known as dehydroepiandrosterone (DHEA) is a major C19 steroid produced by the adrenal cortex. It is also produced in small quantities in the testis and the ovary. Dehydroepiandrosterone (DHEA) can be converted to testosterone; androstenedione; estradiol; and estrone. Most of DHEA is sulfated (dehydroepiandrosterone sulfate) before secretion.
In the United States, DHEA or DHEAS have been advertised with claims that they may be beneficial for a wide variety of ailments. DHEA and DHEAS are readily available in the United States, where they are marketed as over-the-counter dietary supplements. In November 2016, DHEA was approved (as Intrarosa) to treat women experiencing moderate to severe pain during sexual intercourse (dyspareunia), a symptom of vulvar and vaginal atrophy (VVA), due to menopause.
In Canada, a prescription is required to buy DHEA.] |
|
2-propenyl-N-acetyl-neuramic acid
|
DB01716 |
|
|
7,8-Diamino-Nonanoic Acid
|
DB01715 |
|
|
Cetrimonium
|
DB01718 |
[Cetrimonium is a quaternary ammonium cation whose salts are used as antiseptics.] |
|
Bis(Adenosine)-5'-Pentaphosphate
|
DB01717 |
|
|
(3r)-4-(P-Toluenesulfonyl)-1,4-Thiazane-3-Carboxylicacid-L-Phenylalanine Ethyl Ester
|
DB01712 |
|
|
2,3,4,5,6-Pentafluorobenzyl Alcohol
|
DB01711 |
|
|
N-Methyl-Lysine
|
DB01714 |
|
|
UDP-alpha-D-xylose
|
DB01713 |
[The decarboxylation product of UDPglucuronic acid, which is used for formation of the xylosides of seryl hydroxyl groups in mucoprotein synthesis. Also forms plant xylans.] |
|
Porphyrin Fe(III)
|
DB01710 |
|
|
Poldine
|
DB13507 |
|
|
TOP-1288
|
DB14839 |
[TOP-1288 is under investigation in clinical trial NCT02888379 (Phase 2a Study to Evaluate the Safety/Tolerability and Efficacy of TOP1288 200 mg Rectal Solution Once Daily for 4 Weeks in Ulcerative Colitis).] |
|
Telisotuzumab
|
DB14838 |
[Telisotuzumab is under investigation in clinical trial NCT01472016 (Study of ABT-700 in Subjects With Advanced Solid Tumors).] |
|
Cloranolol
|
DB13508 |
|
|
Aloxiprin
|
DB13509 |
|
|
Tyrothricin
|
DB13503 |
[Tyrothricin is an antibiotic peptide complex produced and extracted from the aerobic Gram-positive bacillus Brevibacillus parabrevis [L4019, L4021, A32851] which was previously categorized as Bacillus brevis and Bacillus aneurinolyticus [A36353]. This complex is a mixture comprised of 60% tyrocidine cationic cyclic decapeptides (consisting largely of the six predominant tyrocidines, TrcA/A1, TrcB/B1, TrcC/C1, and other more minor contributors) and 40% neutral linear gramicidins (where valine-gramicidin A is often the major gramicidin present, although the mixture composition can vary) [L4019, L4021, L4022]. Moreover, tyrothricin possesses broad spectrum Gram-positive antibacterial and antifungal activity that has not seen many - if any - significant reportings of microbial resistance during the over 60 years of therapeutic use the complex has provided [A36360]. Nevertheless, as tyrothricin is both cytolytic and hemolytic, it does demonstrate systemic toxicity [L4019, L4021, L4022], although certain formulations that are safe for human use like throat lozenges do exist [L4028].] |
|
SUVN-G3031
|
DB14835 |
[SUVN-G3031 is under investigation in clinical trial NCT02342041 (A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-G3031 in Healthy Subjects).] |
|
Olendalizumab
|
DB14834 |
[Olendalizumab is under investigation in clinical trial NCT01883544 (Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ALXN1007 in Healthy Male and Female Subjects).] |
